EDGAR Filing Documents for 0001209191-13-044232

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001209191-13-044232

Filing Date

2013-09-13

Accepted

2013-09-13 19:07:10

Documents

Period of Report

2013-09-11

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4 SUBMISSION	doc4.html	4
1	FORM 4 SUBMISSION	doc4.xml	4	15111
	Complete submission text file	0001209191-13-044232.txt		16608

Mailing Address C/O SPIROS DEVELOPMENT CORP II INC 7475 LUSK BLVD SAN DIEGO CA 92121

Business Address

KABAKOFF DAVID S (Reporting) CIK: 0001024008 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34828 | Film No.: 131097390
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121

Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370

Trius Therapeutics Inc (Issuer) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences